'Coronary angiography' diaporamas de présentation

New Drug-Eluting Stents

New Drug-Eluting Stents. Soo-Joong Kim M.D., PhD. Department of Cardiology, Internal Medicine, Kyung Hee University Medical Center. Drug-Eluting Stents. Impressive clinical benefits Safety concerns : stent thrombosis patient factors lesion factors

2.74k views • 100 slides

Supersize Me?

Supersize Me?. Brian W. Zagol, M.D. Dan Dishmon, M.D. Department of Cardiology University of Tennessee. The Good, the Fat, and the Ugly. Introduction. We have all been taught that obesity is bad.

743 views • 62 slides

Diagnosis and Management of Chest Pain and Acute Coronary Syndrome (ACS)

Diagnosis and Management of Chest Pain and Acute Coronary Syndrome (ACS). Unstable Angina/NSTEMI. Case # 1 Ms. S.A. 44 female with new onset RSCP When did pain begin? 4/7 days What were you doing?-swimming How long did it last?-15minutes Recur?-yesterday, off and on for 3 hours

1.12k views • 62 slides

Fluoroscopy Safety

Fluoroscopy Safety . New Wisconsin Regulations. In 2010, WI enacted new training regulations for clinicians who use fluoroscopy. Unless certified by the American Board of Radiology (or board eligible), clinicians are required to be trained in:

2.04k views • 58 slides

608 views • 52 slides

Optimization of Radiation Protection in Cardiology

Optimization of Radiation Protection in Cardiology. L 9. Educational Objectives. Optimization in interventional cardiology Ways to improve the radiation protection aspect of procedure (balancing diagnostic information versus patient doses)

762 views • 51 slides

Advanced Cardiac Imaging for the Internist

736 views • 46 slides

GI Board Review 06-01-10

GI Board Review 06-01-10. 109.

570 views • 45 slides

PRE-OPERATIVE CARDIAC EVALUATION FOR VASCULAR SURGERY

799 views • 30 slides

Coronary Anomalies & Staged Revascularization

Coronary Anomalies & Staged Revascularization. Jason S. Finkelstein, M.D. Tulane University HSC Cardiology Division 2/5/04. Definitions. A coronary artery or arterial branch is any vessel that carries blood to the cardiac parenchyma

544 views • 25 slides

Brief History of Cardiac Catheterisation

Brief History of Cardiac Catheterisation . Gemma C. Ryder g.c.ryder@qmul.ac.uk. Intra-cardiac catheter. A thin tube passed to the heart via a vein or artery Used to withdraw blood Measure pressure in heart chambers or great vessels Inject contrast media

1.09k views • 24 slides

A D M I R A L

ADMIRAL. ADMIRAL Study. A D M I R A L. Abciximab before Direct Angioplasty and Stenting in Myocardial Infarction Regarding Acute and Long term follow-up. Aim of the Study.

382 views • 24 slides

A D M I R A L

ADMIRAL. ADMIRAL Study. A D M I R A L. Abciximab before Direct Angioplasty and Stenting in Myocardial Infarction Regarding Acute and Long term follow-up. Aim of the Study.

333 views • 24 slides

Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy gbiondizoccai@gmail.com

INVASIVE AND INTERVENTIONAL CARDIOLOGY: KEY STEPS. Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy gbiondizoccai@gmail.com. INVASIVE CARDIOLOGY. INVASIVE CARDIOLOGY.

796 views • 23 slides

Stable angina

Stable angina. Implementing NICE guidance. July 2011. NICE clinical guideline 126. What this presentation covers. Background Epidemiology Scope Key priorities for implementation Further recommendation areas Costs and savings Discussion Find out more . Background. Stable angina is:

557 views • 22 slides

Does angiography help in risk stratification?

Does angiography help in risk stratification?. Derek Harrington Maidstone and Tunbridge Wells NHS Trust. Medium sized DGH 300,000 population Two Consultant Cardiologists Derek Harrington Clive Lawson. Kent and Sussex Hospital, Tunbridge Wells. Derek and Clive.

217 views • 21 slides

Why coronary CT is inferior to invasive coronary angiography

338 views • 20 slides

Surrogate Measures of Atherosclerosis and Implications for Evaluating Cardiovascular Risk

Surrogate Measures of Atherosclerosis and Implications for Evaluating Cardiovascular Risk. Nathan D. Wong, Ph.D., F.A.C.C. Associate Professor and Director Heart Disease Prevention Program University of California, Irvine. Why use surrogate measures?.

376 views • 19 slides

Heart Failure in the Setting of Ischemic Heart Disease

Heart Failure in the Setting of Ischemic Heart Disease. HFSA 2010 Recommendations. HFSA 2010 Practice Guideline HF and Ischemic Disease. Evaluation for CAD Recommendation 13.1

432 views • 17 slides

Tips for maximizing your performance on Step 1

Answering Board-style Questions. Tips for maximizing your performance on Step 1. How do they comprise a test that is written for you to fail?. A physician sits and writes a question based upon the discipline they want to assess A psychologist rewords the question the way your mind thinks..

225 views • 14 slides